CD274 and esophageal adenocarcinoma: CheckMate 649 is the most robust dataset to date to report PD-L1 CPS ≥ 5 prevalence using an analytically validated assay (28-8 pharmDx) in gastric, GEJ or oesophageal adenocarcinoma.